/Tag: Immuno-Oncology

Nexcelom Bioscience Launches the Cellaca™ MX at AACR

Nexcelom Bioscience, a leading provider of cell counting and characterization products for the life science industry, announced the launch of the revolutionary high throughput, high-speed automated cell counter – Cellaca™ MX.

By |2019-04-01T14:12:03+00:00April 1st, 2019|Categories: Latest News|Tags: , |0 Comments
Read More

Video Workflow-at-a-Glance: NK Cell-Mediated Cytotoxicity Assay

Directly image and count calcein AM-labeled target cells in a 96-well plate using Celigo image cytometer. Concurrent imaging and analysis in 8 minutes.

By |2018-12-03T17:43:53+00:00December 3rd, 2018|Categories: Celigo Application News, Latest News|Tags: , , , , |0 Comments
Read More

Benefits of direct high-throughput cell counting in immuno-oncology research

By directly imaging and counting every cell in a well over a course of a drug treatment, the Celigo can perform the cytotoxicity assays in a label-free format.

By |2018-10-24T14:26:13+00:00October 27th, 2016|Categories: Celigo Application News|Tags: , , , , , , |0 Comments
Read More
Nexcelom Bioscience LLC. | 360 Merrimack Street, Suite 200 | Lawrence, MA 01843 USA Telephone: +1 978.327.5340 or +44 (0) 161 232 4593 | Fax: 978.327.5341 (USA only) | Email: info@nexcelom.com | UK Office: Unit 5, Rutherford House, Pencroft Way | Manchester Science Park, Manchester M15 6SZ | www.nexcelom.com © 2003-2019 Nexcelom Bioscience LLC. All Rights Reserved. Nexcelom products are for RESEARCH USE ONLY and are not approved for diagnostic or therapeutic use.